A Woman's Journey: New Treatment for Depression
Healthcare & Medicine • 59m
There's good news for people who suffer with severe treatment-resistant depression. Esketamine is a groundbreaking therapy that may provide relief from major depression within hours. Join this livestream to hear psychiatrist Erica Richards, chair and medical director of the Department of Psychiatry and Behavioral Health at Sibley Memorial Hospital, describe who is a candidate for esketamine, which is derived from an anesthetic called ketamine, and how it works, and psychopharmacologist Roland Griffiths, Professor in the Departments of Psychiatry and Neurosciences at the Johns Hopkins University School of Medicine, will tell us about psilocybin research and risk factors of the drug. To learn more, visit jhu.edu/hopkinsathome
Up Next in Healthcare & Medicine
-
A Woman's Journey: COVID One Year Later
Recently, Johns Hopkins Medicine’s A Woman’s Journey conducted a national survey of more than 25,000 adults to identify the three COVID-19 issues that are of greatest concern and interest to consumers. The results — public health guidelines, vaccine safety and lingering COVID-19 effects — will be...
-
How the Ear Hears, and What We Can Do...
Ever wondered exactly how your ears hear? Does more time using earbuds on your Zoom calls have you worried about hearing loss? Advances in cellular biology and genetics have helped define the molecular mechanisms by which sound is transduced and transmitted to the brain. With this expanding knowl...
-
A Woman's Journey: New Findings from ...
Preventive cardiologist and women’s heart health expert, Dr. Erin Michos, reviews new findings released at the most recent annual American Heart Association Scientific Sessions.
Erin D. Michos, MD, MHS '07 is an Associate Professor of Medicine within the Division of Cardiology at Johns Hopkins S...
